Assets of XTL BIOPHARMACEUTICALS LTD from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
XTL BIOPHARMACEUTICALS LTD quarterly Assets in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • XTL BIOPHARMACEUTICALS LTD Assets for the quarter ending 31 Dec 2024 was $8,550,000, a 252% increase year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

XTL BIOPHARMACEUTICALS LTD Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $8,550,000 +$6,124,000 +252% 31 Dec 2024 20-F 30 Apr 2025 2024 FY
Q2 2024 $5,842,000 14 Aug 2024 20-F 30 Apr 2025 2024 FY
Q4 2023 $2,426,000 -$1,760,000 -42% 31 Dec 2023 20-F 30 Apr 2025 2024 FY
Q4 2022 $4,186,000 -$2,432,000 -37% 31 Dec 2022 20-F 22 Mar 2023 2022 FY
Q2 2022 $5,757,000 -$1,196,000 -17% 30 Jun 2022 6-K 24 Aug 2022 2022 Q2
Q4 2021 $6,618,000 +$115,000 +1.8% 31 Dec 2021 20-F 22 Mar 2023 2022 FY
Q2 2021 $6,953,000 30 Jun 2021 6-K 24 Aug 2021 2021 Q2
Q4 2020 $6,503,000 -$709,000 -9.8% 31 Dec 2020 20-F 30 Mar 2022 2021 FY
Q4 2019 $7,212,000 -$1,363,000 -16% 31 Dec 2019 20-F/A 19 May 2021 2020 FY
Q4 2018 $8,575,000 +$1,989,000 +30% 31 Dec 2018 20-F 12 Mar 2020 2019 FY
Q4 2017 $6,586,000 +$3,569,000 +118% 31 Dec 2017 20-F 11 Mar 2019 2018 FY
Q4 2016 $3,017,000 31 Dec 2016 20-F 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.